Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders

Details for Australian Patent Application No. 2004251712 (hide)

Owner Auspex Pharmaceuticals, Inc.

Inventors Tse, Bruno; Sarshar, Sepehr; Hong, Borcherng

Agent Freehills

Pub. Number AU-A-2004251712

PCT Pub. Number WO2005/000233

Priority 60/480,950 23.06.03 US

Filing date 3 June 2004

Wipo publication date 6 January 2005

International Classifications

C07C 49/115 (2006.01) Ketones

A61K 31/12 (2006.01) - Ketones

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

C07C 49/23 (2006.01) Ketones

C07C 49/76 (2006.01) Ketones

C07D 311/78 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 335/04 (2006.01) Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/000233 Priority application(s): WO2005/000233

19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251717-Treatment of amyloidand epileptogenesis-associated diseases

2004251710-Compositions and methods for treatment of rosacea